There are only a few spaces left for the forthcoming E-Cigarette Summit which will take place in London on 17th November at The Royal Society. If you would like to view the programme or book a place please go to www.e-cigarette-summit.com .
This year has an unrivalled line up of speakers including Prof Neal Benowitz a global expert on nicotine, Pro David Spiegelhalter who is the Winton Professor of the Public Understanding of Risk from Oxford University and Tom Miller The Attorney General of Iowa, who historically led the successful multibillion dollar lawsuit against the tobacco industry for knowingly misrepresenting the risks of smoking.
At the Summit, AG Miller will look at whether the public are being given accurate information on e-cigarettes.
The key debates this year will include:
Communicating Research and Evidence on E-Cigarettes: How do you convey the relative risks of smoking and e-cigarettes based on what is currently known about them?
Should Nicotine Use Be Accepted in Society – What are the absolute and relative risks?
Will regulation support or stifle the disruptive potential that e-cigarettes pose to the tobacco industry and smoking?
Can there be a balanced debate on e-cigarettes and harm reduction, when there is no consensus on where the “middle ground” lies.
2017 will be a watershed year for electronic cigarettes as new regulations come in to effect across Europe and America. These first attempts to regulate an entirely novel product category will set the agenda for decades to come and is likely to be viewed as a pivotal era in both tobacco control and combustible tobacco use in the future. On the International arena, The Summit is immediately after FCTC COP7 and it will be the first opportunity to examine and discuss the scientific responses and reactions to the likely position that the WHO recommend on e-cigarettes and harm reduction. The importance of this cannot be underestimated. The role that the WHO and the FCTC play in setting public health agendas and tobacco control policies is the single most important framework that those dedicated to reducing smoking related and tobacco death and disease has worked within.
Good regulation and policy is essential to ensure that consumers and the broader public health are protected from corporate invested interests and that products are safe, effective and marketed appropriately. How far regulation has to go to deliver these goals can only be informed by well-structured research and balanced analysis and communication of evidence. The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest evidence in context of public health concerns. Knowing how to accurately convey information to the public, especially adult smokers about the available evidence on the harm of e-cigarettes has also been a contentious issue. The number of people who believe that vaping is as dangerous as smoking has tripled since 2012, which some would argue is an appropriate caution for an addictive product, but very few scientists would argue that this is an accurate assessment- given the known harms of smoking.
The E-Cigarette Summit provides a unique opportunity to examine the latest research and to discuss how the evidence should be interpreted and communicated to deliver the most effective health strategies to reduce smoking related death and disease.
Confirmed speakers include:
- Prof. Ann McNeill (Chair Person) – Professor of Tobacco Addiction (UKCTAS)
- Attorney General Tom Miller – Attorney General for Iowa, USA
- Prof Neal Benowitz – Professor of Medicine and Bioengineering & Therapeutic Sciences, University of California, San Francisco, USA
- Prof. Jean Francois Etter – Professor of Public Health, University of Geneva, Switzerland
- Mr Ram Moorthy – Deputy Chair of the BMA board of science, British Medical Association (BMA)
- Prof. Robert West – Professor of Health Psychology and Director of Tobacco Studies (CRUK)
- Tim Baxter – Head of Public Health Policy and Strategy Unit, Department of Health (DoH)
- Martin Dockrell – Tobacco Lead, Public Health England (PHE), Alcohol Drugs and Tobacco
- Beryl Keeley – E-cigarette Notification Scheme Lead, Medicines and Healthcare Regulatory Authority (MHRA)
- Prof David Spiegelhalter – Winton Professor for the Public Understanding of Risk, Centre for Mathematical Sciences, Cambridge University
- Tim Phillips – Managing Director, ECigIntelligence.com
- Louise Ross – Stop Smoking Services and Tobacco Control Manager, Leicestershire NHS Trust
- Prof. Marcus Munafo – Professor of Biological Psychology, University of Bristol
- Prof. Peter Hajek – Professor of Clinical Psychology, Queen Mary University, London
- Dr Konstantinos Farsalinos – Researcher, Onassis Cardiac Surgery Centre, Greece
- Prof. Ricardo Polosa – Director of the Institute for Internal Medicine, University of Catania
- Prof. Linda Bauld – Professor of Health Policy, University of Stirling and UKCTAS
- Fraser Cropper – CEO, Totally wicked and Chair of IBVTA (Independent British Vape Trade Association)
- Dr Lynne Dawkins – Associate Professor of Psychology, School of Applied Sciences, London South Bank University
- Deborah Arnott – Chief Executive Officer, Action on Smoking (ASH)
- Prof Scott Leischow – Mayo Clinic, USA
- Prof. David Abrams – Professor , The John Hopkins Bloomberg School of Public